Literature DB >> 9861206

The evolution of clinical trials: inclusion and representation.

P A Rochon, P B Berger, M Gordon.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  1998        PMID： 9861206      PMCID： PMC1229855     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Evaluating minority recruitment into clinical studies: how good are the data?

Authors:  R B Ness; D B Nelson; S K Kumanyika; J A Grisso
Journal:  Ann Epidemiol       Date:  1997-10       Impact factor: 3.797

2.  Recruitment and retention of homeless mentally ill participants in research.

Authors:  R L Hough; H Tarke; V Renker; P Shields; J Glatstein
Journal:  J Consult Clin Psychol       Date:  1996-10

Review 3.  Clinical trials in the elderly. Should we do more?

Authors:  H J Cameron; B O Williams
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

4.  Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.

Authors:  P A Rochon; J P Clark; M A Binns; V Patel; J H Gurwitz
Journal:  CMAJ       Date:  1998-08-25       Impact factor: 8.262

5.  A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Authors:  S L Rogers; M R Farlow; R S Doody; R Mohs; L T Friedhoff
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

6.  Reporting of age data in clinical trials of arthritis. Deficiencies and solutions.

Authors:  P A Rochon; P R Fortin; K B Dear; K L Minaker; T C Chalmers
Journal:  Arch Intern Med       Date:  1993-01-25
  6 in total
  8 in total

1.  The invisible hand of the marketing department.

Authors: 
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

2.  A model for the design and implementation of a participant recruitment registry for clinical studies of older adults.

Authors:  N Maritza Dowling; Nevin Olson; Thomas Mish; Preethy Kaprakattu; Carey Gleason
Journal:  Clin Trials       Date:  2012-01-24       Impact factor: 2.486

3.  Missing data: a special challenge in aging research.

Authors:  Susan E Hardy; Heather Allore; Stephanie A Studenski
Journal:  J Am Geriatr Soc       Date:  2009-02-10       Impact factor: 5.562

4.  Spiralling Medical Costs: Why Canada Needs NICE Medicine.

Authors:  Norman J Temple
Journal:  Healthc Policy       Date:  2007-11

5.  Cholinesterase inhibitors and adverse pulmonary events in older people with chronic obstructive pulmonary disease and concomitant dementia: a population-based, cohort study.

Authors:  Anne Stephenson; Dallas P Seitz; Hadas D Fischer; Andrea Gruneir; Chaim M Bell; Andrea S Gershon; Longdi Fu; Geoff M Anderson; Peter C Austin; Paula A Rochon; Sudeep S Gill
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

6.  Prevalence of industry support and its relationship to research integrity.

Authors:  Patricia M Tereskerz; Ann B Hamric; Thomas M Guterbock; Jonathan D Moreno
Journal:  Account Res       Date:  2009 Apr-Jun       Impact factor: 2.622

7.  Does offering an incentive payment improve recruitment to clinical trials and increase the proportion of socially deprived and elderly participants?

Authors:  Claudine G Jennings; Thomas M MacDonald; Li Wei; Morris J Brown; Lewis McConnachie; Isla S Mackenzie
Journal:  Trials       Date:  2015-03-07       Impact factor: 2.279

8.  Best strategies to recruit and enroll elderly Blacks into clinical and biomedical research.

Authors:  Lennox A Graham; Julius Ngwa; Oyonumo Ntekim; Oludolapo Ogunlana; Saba Wolday; Steven Johnson; Megan Johnson; Chimene Castor; Thomas V Fungwe; Thomas O Obisesan
Journal:  Clin Interv Aging       Date:  2017-12-22       Impact factor: 4.458
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.